- Home
- YDES vs GAU Comparison
YDES vs GAU Comparison
Compare YDES & GAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | YDES | GAU |
|---|---|---|
| Founded | 2013 | 1999 |
| Country | Taiwan | Canada |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 543.0M | 627.8M |
| IPO Year | 2024 | 2006 |
Fundamental Metrics
Financial Performance| Metric | YDES | GAU |
|---|---|---|
| Price | $4.18 | $2.27 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.08 |
| AVG Volume (30 Days) | 174.8K | ★ 2.8M |
| Earning Date | 05-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $82.77 |
| Revenue Next Year | N/A | $29.09 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.70 | $1.66 |
| 52 Week High | $25.00 | $3.62 |
Technical Indicators
Market Signals| Indicator | YDES | GAU |
|---|---|---|
| Relative Strength Index (RSI) | 57.16 | 55.53 |
| Support Level | $1.99 | $2.14 |
| Resistance Level | $5.15 | $2.45 |
| Average True Range (ATR) | 0.84 | 0.10 |
| MACD | -0.09 | -0.01 |
| Stochastic Oscillator | 49.21 | 43.06 |
Price Performance
Historical ComparisonAbout YDES YD Bio Limited Ordinary Shares
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.
About GAU Galiano Gold Inc.
Galiano Gold Inc is focused on building a sustainable business capable of long term value creation for its stakeholders through a combination of exploration, accretive acquisitions, and disciplined deployment of its financial resources. The company currently operates and manages: Nkran, Esaase, Abore and Miradani North, multiple satellite deposits and exploration projects located on the Asankrangwa Gold Belt in the Amansie West District of the Republic of Ghana (Ghana), West Africa.